Jim Cramer Says Oracle Is Okay, But He Really Likes Salesforce.com

TheStreet’s Jim Cramer discussed the bear market in biotechs while answering viewer questions from social media on Friday. A viewer asked about Regeneron (REGN), and Cramer responded ‘I’m not going to say don’t buy Regeneron, not down here. I like it.’ Cramer also talked about how Celgene (CELG), Biogen (BIIB) and Amgen (AMGN) have all been slammed. Cramer was asked about Oracle (ORCL) and he said the stock is okay, but he likes Salesforce.com (CRM), which is winning business. A viewer wanted to know about Nestle (NSRGY), and Cramer said if the dollar has peaked, it’s not a good long term play. He does like Coca-Cola (KO), which he believes will move much higher. Cramer is portfolio manager of Action Alerts PLUS. Send your questions to Cramer on Facebook or Twitter, use hashtag CramerQ.